Kalaris Therapeutics, Inc. (KLRS) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-2.85 | +94.5% |
| 2024 | $-51.77 | -23.0% |
| 2023 | $-42.09 | -1813.2% |
| 2022 | $-2.20 | +19.7% |
| 2021 | $-2.74 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-2.85 | +94.5% |
| 2024 | $-51.77 | -23.0% |
| 2023 | $-42.09 | -1813.2% |
| 2022 | $-2.20 | +19.7% |
| 2021 | $-2.74 | — |